Roger Jensen

Chief Financial Officer

President of Centennial Capital Corporation, a financial advisory firm specializing in Mergers and Acquisitions, Corporate Finance and Reorganization, and Strategic Growth Planning. Roger has over 35 years senior management experience in a variety of industries including life science, and has been engaged with GMD since 2012. From 1997-2001 he served as Executive Vice President for Apogent Technologies where he had the lead role in creating and managing Apogent’s $200 million Microbiology Group. In this and other corporate capacities, he has developed and successfully introduced numerous diagnostic products into both the clinical and research markets. He has earned an MBA and CPA, having started his career with KPMG (formerly Peat, Marwick) in their business advisory practice. He brings to GeneSTAT significant business, management and financial expertise.